Back to search results

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Congestive Heart Failure · Heart Failure, Systolic · Heart Failure · HFrEF - Heart Failure With Reduced Ejection Fraction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • San Diego Cardiac Center, San Diego, California, United States

    Contact: Study coordinator (Emma Burkhalter, RN) · eburkhalter@sdcardiac.com · 858-244-6890
    Contact: Principal Investigator (Brian Jaski, MD)

  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Kaye Reambonanza) · Kaye.Reambonanza@ucsf.edu · 415-514-6147
    Contact: Principal Investigator (Richard Cheng, MD)

  • Washington University in Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Annie Dirks, RN, BSN) · aplatts@wustl.edu · 314-454-8711
    Contact: Principal Investigator (Gregory Ewald, MD)

  • University of Texas Southwestern Medical Center, Dallas, Texas, United States

    Contact: Study coordinator (Therese Villina, MPHI, BSN) · Therese.Vallina@utsouthwestern.edu · 214-645-7083
    Contact: Principal Investigator (Justin Grodin, MD)

  • University of Washington Medicine, Seattle, Washington, United States

    Contact: Study coordinator (Katherine Nassans) · Knassans@uw.edu · 206-543-6850
    Contact: Principal Investigator (Kenta Nakamura, MD)
View source on ClinicalTrials.gov(opens in a new tab)